Description
Panelists Bradley J. Monk, MD; Matthew Powell, MD; Gottfried E. Konecny, MD; Robert L. Coleman, MD; and Katie Moore, MD, discuss the FDA approval of niraparib and the NOVA trial of niraparib maintenance therapy in recurrent platinum-sensitive ovarian cancer.
Tags
cancer oncology